Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
S Afr Med J ; 108(6): 506-510, 2018 May 25.
Artigo em Inglês | MEDLINE | ID: mdl-30004332

RESUMO

BACKGROUND: Ureteral stenting is generally a theatre-based procedure that requires a multidisciplinary team and on-table imaging. Limited hospital bed numbers and theatre time in our centre in Cape Town, South Africa, have led us to explore an alternative approach. OBJECTIVES: To see whether outpatient insertion of ureteric stents under local anaesthesia without fluoroscopy was a possible and acceptable alternative to theatre-based ureteral stenting. METHODS: Ureteral stenting (double-J stents and ureteric catheters) was performed with flexible cystoscopy under local anaesthesia and chemoprophylaxis, but without fluoroscopic guidance, in an outpatient setting. Every patient had an abdominal radiograph and an ultrasound scan of the kidney after the procedure to confirm stent position. RESULTS: Three hundred and sixteen procedures (276 double-J stents and 40 ureteric catheters) were performed in 161 men and 155 women. The overall success rate for the procedures was 85.4%, independent of gender (p=0.87), age (p=0.13), type of device inserted (p=0.81) or unilateral/bilateral nature of the procedure (p=1.0). Procedures with a successful outcome were performed in a significantly (p<0.0001) shorter median time (10 minutes (interquartile range (IQR) 5 - 15)) than failed procedures (20 minutes (IQR 10 - 30)). Patients with a pain score of >5 experienced a significantly (p=0.02) greater proportion of failure (27.3%) than patients with a pain score of ≤5 (12.5%). Difficulties were encountered in 23.7% of procedures, with a significantly higher proportion being registered in failed interventions compared with successful ones (82.6% v. 13.7%; p<0.0001). CONCLUSIONS: The procedure was easily mastered and technically simple, and represents savings in cost, time and human resources in our setting.

2.
Transpl Infect Dis ; 9(1): 62-5, 2007 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-17313477

RESUMO

Only localized cases of Mycobacterium chelonae osteomyelitis have been reported. In this article, a 55-year-old immunosuppressed man with M. chelonae osteomyelitis and multiple spinal and extra-spinal involvement is presented. The patient had nodule-pustular skin lesions, spondylodiscitis at multiple levels, and osteolytic lesions at extra-spinal locations. Biopsy and cultures of the osseous lesions showed M. chelonae osteomyelitis. The patient started antimycobacterial chemotherapy with ciprofloxacin and clarithromycin. Progressive cervical kyphosis associated with anterior wedged deformity of the C5 vertebra and posterior C5-C6 spondylolisthesis resulted in compression of the spinal cord and neurological impairment. The patient underwent anterior decompression and C4-C6 arthrodesis using a titanium mesh cage and cervical plate. About 15 months after the initiation of chemotherapy and 5 months after surgery, the patient was pain free, with significant improvement of his neurological function. In the presence of immunosuppression, the physician should be alert for unusual or opportunistic pathogens of osteomyelitis. Long-term antimicrobial chemotherapy and surgical intervention is the cornerstone of successful treatment of multifocal bone M. chelonae infection.


Assuntos
Discite/etiologia , Transplante de Rim/efeitos adversos , Infecções por Mycobacterium não Tuberculosas/etiologia , Mycobacterium chelonae , Osteomielite/etiologia , Complicações Pós-Operatórias , Tuberculose da Coluna Vertebral/etiologia , Anti-Infecciosos/uso terapêutico , Vértebras Cervicais/patologia , Ciprofloxacina/uso terapêutico , Claritromicina/uso terapêutico , Rejeição de Enxerto/prevenção & controle , Humanos , Imunossupressores/administração & dosagem , Cifose/etiologia , Masculino , Pessoa de Meia-Idade , Fatores de Risco
3.
Exp Clin Endocrinol Diabetes ; 111(6): 370-3, 2003 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-14520605

RESUMO

The effect of acute repaglinide administration (2 mg) on postprandial glycaemia and lipaemia has been examined in 20 subjects with type 2 diabetes mellitus. Each subject received in the morning, after a 12 to 14 h fast, a standard mixed meal (total energy 783 kcal), preceded by one tablet of 2 mg repaglinide or placebo. Chylomicrons and chylomicron-deficient plasma were prepared by ultracentrifugation. Triglyceride levels in CM fraction (CM-triglycerides) in total plasma as well as in CM-deficient plasma (non-CM-triglycerides) were determined. A significant reduction in postprandial glycaemia was observed after repaglinide administration compared to placebo ( p < 0.001). Plasma concentrations of total triglycerides, CM-triglycerides, non-CM-triglycerides, free fatty acids and the other plasma lipids measured, were not significantly different between the two phases of the study. It is concluded that, in contrast to sulphonylureas, acute repaglinide administration does not improve postprandial lipaemia in patients with type 2 diabetes.


Assuntos
Carbamatos/uso terapêutico , Diabetes Mellitus Tipo 2/tratamento farmacológico , Hiperlipidemias/sangue , Piperidinas/uso terapêutico , Análise de Variância , Glicemia/metabolismo , Peptídeo C/sangue , Colesterol/sangue , Diabetes Mellitus Tipo 2/sangue , Ácidos Graxos não Esterificados/sangue , Hemoglobinas Glicadas/metabolismo , Humanos , Hiperlipidemias/tratamento farmacológico , Hipoglicemiantes/uso terapêutico , Insulina/sangue , Cinética , Período Pós-Prandial , Triglicerídeos/sangue
4.
Antimicrob Agents Chemother ; 43(3): 714-6, 1999 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-10049299

RESUMO

A biodegradable polymer of DL-dilactide that facilitates release of ciprofloxacin or pefloxacin at levels exceeding MICs for the causative microorganisms of chronic osteomyelitis is described. Duration and peak of release were found to depend on the molecular weight of the polymer. Its characteristics make it promising for treating chronic bone infections.


Assuntos
Anti-Infecciosos/química , Ácido Láctico , Polímeros , Anti-Infecciosos/administração & dosagem , Ciprofloxacina/administração & dosagem , Ciprofloxacina/química , Dioxanos/química , Portadores de Fármacos , Ácido Láctico/química , Peso Molecular , Pefloxacina/administração & dosagem , Pefloxacina/química , Poliésteres , Polímeros/química , Solubilidade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA